Vanda Pharmaceuticals (VNDA) Shares Outstanding (Diluted Average) (2009 - 2026)

Vanda Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 18 years of filings, most recently posting $59.5 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $59.5 million, up 1.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.5 million (up 1.59% YoY), and the FY2025 annual result was $58.9 million, up 1.34% from the prior year.
• Shares Outstanding (Diluted Average) came in at $59.5 million for Q1 2026 at Vanda Pharmaceuticals, up from $58.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $59.5 million in Q1 2026 to a low of $56.1 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $57.8 million (2024), against an average of $57.8 million.
• Across the five-year window, Shares Outstanding (Diluted Average) decreased 1.05% in 2022 and advanced 2.31% in 2023, its largest moves.
• Vanda Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $57.0 million in 2022, then rose by 1.01% to $57.6 million in 2023, then gained by 1.03% to $58.1 million in 2024, then rose by 1.34% to $58.9 million in 2025, then gained by 0.9% to $59.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $59.5 million (Q1 2026), $58.9 million (Q4 2025), and $58.9 million (Q3 2025), per Business Quant data.